Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation by Ingrid Kuehnle, M. Helen Huls, Zhensheng Liu, Micah Semmelmann, Robert A. Krance, Malcolm K. Brenner, Cliona M. Rooney, and Helen E. Heslop Blood Volume 95(4):1502-1505 February 15, 2000 ©2000 by American Society of Hematology Epstein-Barr virus DNA levels in 3 patients before and after administration of rituximab. Ingrid Kuehnle et al. Blood 2000;95:1502-1505 ©2000 by American Society of Hematology